Brief: Suven Life Sciences gets product patent in Australia
Jan 23 (Reuters) - Suven Life Sciences Ltd SUVP.NS
* Suven Life Sciences Ltd says Suven Life Sciences secures a
product patent in Australia corresponding to new chemical
entities
* Suven Life Sciences Ltd says Products may be out-licensed
at various phases of clinical development like at phase-I or
phase-ii
* Suven Life Sciences Ltd says patent for the treatment of
disorders associated with neurodegenerative diseases and the
patent is valid through 2033
Source text - (http://bit.ly/2jnzwqQ)
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees